R.H. Bluestein & Co’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-9,000
Closed -$224K 353
2022
Q2
$224K Hold
9,000
0.01% 313
2022
Q1
$303K Hold
9,000
0.01% 288
2021
Q4
$292K Sell
9,000
-1,000
-10% -$32.9K 0.01% 324
2021
Q3
$350K Hold
10,000
0.01% 283
2021
Q2
$416K Hold
10,000
0.02% 256
2021
Q1
$369K Hold
10,000
0.02% 264
2020
Q4
$416K Hold
10,000
0.02% 218
2020
Q3
$425K Hold
10,000
0.02% 183
2020
Q2
$433K Hold
10,000
0.02% 167
2020
Q1
$328K Hold
10,000
0.03% 163
2019
Q4
$368K Hold
10,000
0.02% 225
2019
Q3
$336K Hold
10,000
0.02% 219
2019
Q2
$393K Hold
10,000
0.02% 182
2019
Q1
$405K Hold
10,000
0.02% 162
2018
Q4
$324K Hold
10,000
0.03% 165
2018
Q3
$514K Hold
10,000
0.02% 159
2018
Q2
$504K Hold
10,000
0.03% 156
2018
Q1
$511K Hold
10,000
0.03% 154
2017
Q4
$526K Hold
10,000
0.03% 143
2017
Q3
$489K Hold
10,000
0.03% 161
2017
Q2
$483K Hold
10,000
0.03% 137
2017
Q1
$421K Sell
10,000
-2,100
-17% -$86.8K 0.03% 168
2016
Q4
$511K Buy
12,100
+100
+0.8% +$4.08K 0.03% 124
2016
Q3
$525K Hold
12,000
0.03% 102
2016
Q2
$523K Hold
12,000
0.04% 90
2016
Q1
$529K Hold
12,000
0.04% 120
2015
Q4
$502K Hold
12,000
0.03% 135
2015
Q3
$468K Hold
12,000
0.03% 144
2015
Q2
$499K Hold
12,000
0.03% 175
2015
Q1
$497K Hold
12,000
0.03% 166
2014
Q4
$446K Hold
12,000
0.03% 191
2014
Q3
$416K Hold
12,000
0.03% 222
2014
Q2
$402K Hold
12,000
0.02% 231
2014
Q1
$418K Hold
12,000
0.03% 216
2013
Q4
$427K Hold
12,000
0.03% 212
2013
Q3
$389K Hold
12,000
0.03% 216
2013
Q2
$423K Buy
+12,000
New +$417K 0.04% 186

Other funds holding FMS

R.H. Bluestein & Co's FMS Position: Q3 2022 in Review

R.H. Bluestein & Co sold out of Fresenius Medical Care (FMS) in Q3 2022, closing a stake of 9,000 shares — an estimated $224K sold.

R.H. Bluestein & Co first reported a position in FMS in Q2 2013 and held it in 37 quarters. The position peaked at $529K in Q1 2016. 141 funds tracked by Wall St. Rank hold FMS as of Q3 2022.

  • R.H. Bluestein & Co reported no remaining Fresenius Medical Care position as of Q3 2022 after selling out during the quarter.
  • R.H. Bluestein & Co sold 9,000 Fresenius Medical Care shares in Q3 2022, an estimated $224K.
  • R.H. Bluestein & Co first reported a position in Fresenius Medical Care in Q2 2013 and held it in 37 quarters.
  • R.H. Bluestein & Co's Fresenius Medical Care position peaked at $529K in Q1 2016.
  • 141 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.